1-7 of 7
Mohammed A Marei
Close
Sort by
Journal Articles

Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience

Abdullah M. Alrajhi, Mashael Alrouqi, Jude Howaidi, Mohammmad Alwadi, Hassan Alshehri, Imran K Tailor, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Mohammed A Marei, Muhned Alhumaid
Journal: Blood
Blood (2023) 142 (Supplement 1): 7367.
https://doi.org/10.1182/blood-2023-189082
Published: 2023
Journal Articles

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Manar Aleid, Abdullah Alrajhi, Mohammmad Alwadi, Ali Alsugair, Hassan Alshehri, Imran K Tailor, Amr Hanbali, Feras Abdulaziz Alfraih, Saud Alhayli, Ali Alahmari, Abdulwahab Albabtain, Ahmad S. Alotaibi, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Hazza A Alzahrani, Mohammed A Marei, Ayman Saad, Mahmoud Aljurf, Riad Elfakih, Muhned Alhumaid, Mansour Alfayez
Journal: Blood
Blood (2023) 142 (Supplement 1): 5889.
https://doi.org/10.1182/blood-2023-180221
Published: 2023
Journal Articles

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Marwa Bin Morya, Mohammed A. Marei, Imran K. Tailor, Abdullah M Alrajhi, Adel Alnakhli, Foud Alnajjar, Mohammed S. Alnoamani, Hassan Alshehri, Ibraheem H. Motabi, Nawal AlShehry, Mansour Alfayez
Journal: Blood
Blood (2021) 138 (Supplement 1): 4558.
https://doi.org/10.1182/blood-2021-150242
Published: 2021
Journal Articles

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Mohammmad Alwadi, Jude Howaidi, Abdullah M Alrajhi, Adel Alnakhli, Mohammed A. Marei, Imran K. Tailor, Fouad H. Alnajjar, Syed Y. Altaf, Mohammed S. Alnoamani, Kamal Alzahrani, Hassan Alshehri, Ibraheem H. Motabi, Syed Ziauddin A Zaidi, Nawal F Alshehry, Mansour Alfayez
Journal: Blood
Blood (2021) 138 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2021-153335
Published: 2021
Journal Articles

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Maged Al-Ammari, Abdul Ali Peer Zada, Ibraheem H. Motabi, Belal M. Albtoosh, Syed Y. Altaf, Imran K. Tailor, Mohammed S. Alnoamani, Syed Ziauddin A Zaidi, Mansour Alfayez, Nawal F Alshehry, Mohammed A. Marei
Journal: Blood
Blood (2021) 138 (Supplement 1): 4258.
https://doi.org/10.1182/blood-2021-149560
Published: 2021
Journal Articles

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Abdullah M Alrajhi, Razan A. Aljalali, Lara H. Alghazi, Ibrahim Asiri, Adel Alnakhli, Fouad H. Alnajjar, Nawal F Alshehry, Ibraheem H. Motabi, Mohammed S. Alnoamani, Mohammed A. Marei, Mansour Alfayez, Imran K. Tailor
Journal: Blood
Blood (2021) 138 (Supplement 1): 4532.
https://doi.org/10.1182/blood-2021-152911
Published: 2021
Journal Articles

Comparison of the Impact of Pre-Transplant Co-Morbidity Scores on Allogeneic Hematopoietic Stem Cell Transplant Outcomes

Mohammed A. Marei, Eshetu G Atenafu, MSc, P.Stat, Arjun Law, MD DM, Wilson Lam, MD, Rajat Kumar, MD, Santhosh Thyagu, MD DM, Auro Viswabandya, MD DM, Dennis Dong Hwan Kim, MD, Jeff H. Lipton, MD PhD, Hans A. Messner, MD PhD, Fotios V. Michelis, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4670.
https://doi.org/10.1182/blood-2018-99-113884
Published: 2018